MedPath

Comparision of two doses of a medicine for treating acute asthma attack in children between age of 2 to 5 years

Not yet recruiting
Conditions
Other and unspecified asthma,
Registration Number
CTRI/2020/08/027064
Lead Sponsor
Jawaharlal Institute of Pondicherry Medical Education and Research
Brief Summary

Purpose of study:comparing two doses of a drug called magnesiumsulphate  given through vein anddetermining which is effective for treating a severe case of asthma in  children of 2 to 5 years of age.

-   **Procedure/methods of the study:** If yourchild is 2 to 5 years of age with severe breathing difficulty due to asthmainitial emergency treatment will be given and again condition will bereassessed. If breathing difficulty is still severe, your child will beenrolled in the study and be given a drug called magnesium sulphate injectionwill be given. Your child will be allotted to one group randomly among the tworesearch groups. For one group 25mg/kg dose of drug will be given. Other groupwill receive 50mg/kg. As a parent you will not know the dose of drug that isadministered. Condition will be assessed at every hour till four hours. Even atthe end of four hours if the respiratory difficulty is not improving then yourchild`s treatment will be intensified as per your treating doctor in aintensive care setting.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Children with acute severe asthma with PRAM score 8 or more and continue to be 8 or more one hour post intervention.

Exclusion Criteria

Clinical suspicion of pneumonia Acute kidney injury or hypotension Congenital heart disease and structural airway anomalies that produce wheeze.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Proportion of children in whom intensive care admissions are preventedDuring period of hospitalization for study half an hour, two hours, four hours
Secondary Outcome Measures
NameTimeMethod
To correlate serum magnesium levels to the amount of magnesium sulphate infused and clinical outcomeone hour Before and one hour after injecting magnesium
Side effects of intravenous magnesium sulfate in above age group.During hospital stay.

Trial Locations

Locations (1)

Jawaharlal Institute of Pondicherry Medical Education and Research

🇮🇳

Pondicherry, PONDICHERRY, India

Jawaharlal Institute of Pondicherry Medical Education and Research
🇮🇳Pondicherry, PONDICHERRY, India
Monica
Principal investigator
8978446854
csm.chakicherla@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.